Ebola 2014: CounterMeasures Bonanza

Ebola, Robert Malone, Michael Callahan, ZMapp, Remdesivir, Merck, USAID, Department of Defense, CounterMeasures, Gain-of-Function-Research, Bill Gates, Zika, Mosquitos

November 2014: “The real economic ‘win’ for biotech and pharmaceutical companies will come in the form of government procurement contracts to stockpile and deploy countermeasures.”

This is a pay article. The title pretty much says it all. The original sources I quote extensively here speak for themselves. You will receive the original sources, their text, and a limited commentary from myself in this article.

It will give you a new perspective on the pause in the government’s funding of “Gain-of-Function” research in 2014. It certainly did me. Government funding simply moved into another area and another phase after the “Gain-of-Function” shutdown.” Funding moved to the CounterMeasures response phase to engineered bioweapons, after the US Department of Defense engineered the 2014 Ebola pandemic in West Africa.